These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38534521)

  • 1. Does Liquid/Injectable Platelet-Rich Fibrin Help in the Arthrocentesis Treatment of Temporomandibular Joint Disorder Compared to Other Infusion Options? A Systematic Review of Randomized Clinical Trials.
    Nemeth A; Gurgel BV; Lowenstein A; Juliasse L; Siroma RS; Zhu Z; Shibli JA; Mourão CF
    Bioengineering (Basel); 2024 Mar; 11(3):. PubMed ID: 38534521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the Use of Injectable Platelet-Rich Fibrin After Arthrocentesis for Disc Displacement Without Reduction Improve Clinical Outcomes?
    Işık G; Kenç S; Özveri Koyuncu B; Günbay S; Günbay T
    J Oral Maxillofac Surg; 2023 Jun; 81(6):689-697. PubMed ID: 36924792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of hyaluronic acid, platelet-rich plasma, and platelet-rich fibrin in treating temporomandibular disorders: a systematic review and network meta-analysis.
    Xu J; Ren H; Zhao S; Li Q; Li C; Bao G; Kang H
    Head Face Med; 2023 Aug; 19(1):39. PubMed ID: 37633896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does intra-articular injection of platelet-rich plasma/platelet-rich fibrin improve outcomes after temporomandibular joint arthrocentesis? A systematic review and meta-analysis.
    Nagori SA; Gopalakrishnan V; Rangarajan H; Kulkarni V; Roychoudhury A
    Br J Oral Maxillofac Surg; 2024 Oct; 62(8):676-684. PubMed ID: 39097521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable platelet-rich fibrin as treatment for temporomandibular joint osteoarthritis: A randomized controlled clinical trial.
    Işık G; Kenç S; Özveri Koyuncu B; Günbay S; Günbay T
    J Craniomaxillofac Surg; 2022 Jul; 50(7):576-582. PubMed ID: 35798596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arthrocentesis, Injectable Platelet-Rich Plasma and Combination of Both Protocols of Temporomandibular Joint Disorders Management: A Single-Blinded Randomized Clinical Trial.
    Abbadi W; Kara Beit Z; Al-Khanati NM
    Cureus; 2022 Nov; 14(11):e31396. PubMed ID: 36523721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of platelet rich fibrin (I-PRF) intra-articular injections in the management of internal derangements of temporomandibular joints - a controlled preliminary prospective clinical study.
    Manafikhi M; Ataya J; Heshmeh O
    BMC Musculoskelet Disord; 2022 May; 23(1):454. PubMed ID: 35568935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of arthrocentesis plus platelet-rich plasma and platelet-rich plasma alone in the treatment of temporomandibular joint osteoarthritis: A retrospective matched cohort study (A STROBE-compliant article).
    Lin SL; Tsai CC; Wu SL; Ko SY; Chiang WF; Yang JW
    Medicine (Baltimore); 2018 Apr; 97(16):e0477. PubMed ID: 29668626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of platelet-rich plasma, platelet-rich growth factor with arthrocentesis or arthroscopy to treat temporomandibular joint osteoarthritis: Systematic review with meta-analyses.
    Haigler MC; Abdulrehman E; Siddappa S; Kishore R; Padilla M; Enciso R
    J Am Dent Assoc; 2018 Nov; 149(11):940-952.e2. PubMed ID: 30724168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic criteria for the management of temporomandibular disorders using arthrocentesis with normal saline and arthrocentesis with normal saline and platelet-rich plasma.
    Ansar AS; Munna K; Iqbal A; Mohammad F; Naved A; Shamimul H
    J Med Life; 2022 May; 15(5):698-704. PubMed ID: 35815075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hierarchy of different treatments for arthrogenous temporomandibular disorders: A network meta-analysis of randomized clinical trials.
    Al-Moraissi EA; Wolford LM; Ellis E; Neff A
    J Craniomaxillofac Surg; 2020 Jan; 48(1):9-23. PubMed ID: 31870713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of temporomandibular joint disc displacement using arthrocentesis combined with injectable platelet rich fibrin versus arthrocentesis alone.
    Ghoneim NI; Mansour NA; Elmaghraby SA; Abdelsameaa SE
    J Dent Sci; 2022 Jan; 17(1):468-475. PubMed ID: 35028072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Efficiacy of Intra-Articular Injection of Liquid Platelet-Rich Fibrin and Hyaluronic Acid After in Conjunction With Arthrocentesis for the Treatment of Internal Temporomandibular Joint Derangements.
    Yuce E; Komerik N
    J Craniofac Surg; 2020 Oct; 31(7):1870-1874. PubMed ID: 32433129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis between intra articular injections of injectable platelet rich fibrin versus platelet rich plasma in the management of temporomandibular disorders: A randomized control trial.
    Sharma P; Aurora JK; Dubey KN; Tandon P; Tiwari S
    Natl J Maxillofac Surg; 2023; 14(2):249-255. PubMed ID: 37661973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable Platelet-Rich Fibrin (I-PRF) Administered to Temporomandibular Joint Cavities: A Scoping Review.
    Sielski M; Chęcińska K; Chęciński M; Sikora M
    J Clin Med; 2023 May; 12(9):. PubMed ID: 37176766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of intra-articular injectable platelet-rich fibrin application in the management of Wilkes stage III temporomandibular joint internal derangement.
    Torul D; Cezairli B; Kahveci K
    Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1485-1490. PubMed ID: 33771436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients with disk displacement without reduction of the temporomandibular joint by arthrocentesis alone, plus hyaluronic acid or plus platelet-rich plasma.
    Toameh MH; Alkhouri I; Karman MA
    Dent Med Probl; 2019; 56(3):265-272. PubMed ID: 31577070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which of the autologous blood products administered simultaneously with arthrocentesis is more effective in terms of clinical outcomes?
    Akkaş E; Esen A
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(5S1):101998. PubMed ID: 39097093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-rich plasma injections for the treatment of temporomandibular joint disorders: A systematic review.
    Haddad C; Zoghbi A; El Skaff E; Touma J
    J Oral Rehabil; 2023 Nov; 50(11):1330-1339. PubMed ID: 37341166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of intra-articular injection of injectable platelet-rich fibrin, anterior repositioning splint and arthrocentesis in treatment of temporomandibular joint internal derangement.
    Nasef M; Alashmawy M; Abdelrahman A; Elsaid M; Elwaseef S; Mohamed A
    Br J Oral Maxillofac Surg; 2024 Oct; 62(8):710-715. PubMed ID: 39043507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.